Private Company Director

Vor Biopharma

Submitted by pcd@dmin on Fri, 01/08/2021 - 08:08

Vor Biopharma is an oncology company pioneering engineered hematopoietic stem cell therapies  for the treatment of cancer. Vor's platform could be used to improve the treatment paradigm for patients with blood cancers such as acute myeloid leukemia.

215 First Street
Suite 430
Cambridge, MA 02142
United States

Directors Record